Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn’s disease

Gastroenterology

Volumn 121, Issue 4, 2001, Pages 875-888

  Kanai, Takanori ^a   Watanabe, Mamoru ^a   Okazawa, Akira ^b   Sato, Toshiro ^b   Yamazaki, Motomi ^a   Okamoto, Susumu ^b   Ishii, Hiromasa ^b   Totsuka, Teruji ^a   Iiyama, Ryoichi ^a   Okamoto, Ryuichi ^a   Ikeda, Masao ^c   Kurimoto, Masashi ^c   Takeda, Kiyoshi ^d   Akira, Shizuo ^d   Hibi, Toshifumi ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; INTERLEUKIN 18; INTERLEUKIN 18 ANTIBODY; NEUTRALIZING ANTIBODY; SAPORIN; SAPORIN ANTIBODY; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; MACROPHAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

EID: 0034800289     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.28021     Document Type: Article

References (47)

1. Inflammatory bowel disease (first of two)
2. Immunological diseases of the gastrointestinal tract
3. Role of the intestinal microflora in pathogenesis and complications
4. Dendritic cells and scavenger macrophages in chronic inflammatory bowel disease
5. Changes in phenotypically distinct mucosal macrophage populations may be prerequisite for the development of inflammatory bowel disease
6. Cytokines in intestinal inflammation: Pathophysiological and clinical considerations
7. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease
8. Experimental models of inflammatory bowel disease
9. Mucosal immunoregulation and inflammatory bowel disease: New insights from murine models of inflammation
10. A synthetic mimetic of CD4 is able to suppress disease in a rodent model of immune colitis
11. Antibodies to interleukin 12 abrogate established experimental colitis in mice
12. Up-regulation of the IL-12/STAT-4 signaling pathway distinguishes Crohn's disease from ulcerative colitis
13. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease
14. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells
15. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease
16. Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both
17. Interleukin-18
18. The role of IL-18 in innate immunity
19. Cloning of a new cytokine that induces IFN-γ production by T cells
20. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Esherichia coli, and studied on the biologic activities of the protein
21. A mechanism underlying synergy between IL-12 and IFN-γ-inducing factor in enhanced production of IFN-γ
22. IL-18 and CD28 distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-γ
23. Purification and characterization of the human interleukin-18 receptor
24. Regulation of interferon-γ production by IL-12 and IL-18
25. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: Expression and localization in intestinal mucosal cells
26. Bioactive IL-18 expression is up-regulated in Crohn's disease
27. Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease
28. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12
29. Neutralizing antibodies to IFN-γ-inducing factor prevent experimental autoimmune encephalomyelitis
30. Defective NK cell activity and Th1 response in IL-18-deficient mice
31. IL-18 protects mice against pulmonary and disseminated infection with cryptococcus neoformans by inducing IFN-γ production
32. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor
33. Cytotoxic and interferon γ-producing activities of γδ T cells in the mouse intestinal epithelium are strain dependent
34. Interleukin-7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes
35. Hapten-induced model of murine inflammatory bowel disease
36. Isolation and functional characterization of intestinal mucosal lymphoid cells
37. Detection of intracellular cytokines by flow cytometry
38. The immunology of inflammatory bowel diseases
39. Immunopathology of human inflammatory bowel disease
40. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
41. Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2-/- mice upon transfer of CD4+CD45Rbhi T cells
42. Immunohistochemical and immuno-electron-microscopic detection of interferon-γ-inducing factor ("interleukin-18") in mouse intestinal epithelial cells
43. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with abberant cytokine production and CD4(+) TH1-like responses
44. Clarifying the causes of Crohn's disease
45. Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-converting enzyme (caspase-1)-deficient mice
46. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhiCD4+ T cells
47. Local administration of antisense phosphorothioated oligonucleotides to the p65 subunit of NFκB abrogates established experimental colitis in mice